Vanguard Group’s Genesis Healthcare, Inc. GEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,735,802
| Closed | -$841K | – | 4345 |
|
|
2020
Q4 | $841K | Sell |
1,735,802
-3,000,865
| -63% | -$1.52M | ﹤0.01% | 3863 |
|
|
2020
Q3 | $2.58M | Sell |
4,736,667
-702,332
| -13% | -$505K | ﹤0.01% | 3412 |
|
|
2020
Q2 | $3.75M | Buy |
5,438,999
+1,647,409
| +43% | +$1.32M | ﹤0.01% | 3222 |
|
|
2020
Q1 | $3.2M | Buy |
3,791,590
+799,522
| +27% | +$1.14M | ﹤0.01% | 3160 |
|
|
2019
Q4 | $4.91M | Buy |
2,992,068
+21,050
| +0.7% | +$31.6K | ﹤0.01% | 3181 |
|
|
2019
Q3 | $3.3M | Buy |
2,971,018
+44,583
| +2% | +$51.5K | ﹤0.01% | 3279 |
|
|
2019
Q2 | $3.63M | Buy |
2,926,435
+557,039
| +24% | +$709K | ﹤0.01% | 3273 |
|
|
2019
Q1 | $3.41M | Buy |
2,369,396
+267,522
| +13% | +$397K | ﹤0.01% | 3283 |
|
|
2018
Q4 | $2.48M | Sell |
2,101,874
-322,727
| -13% | -$479K | ﹤0.01% | 3307 |
|
|
2018
Q3 | $3.27M | Buy |
2,424,601
+12,253
| +0.5% | +$19.4K | ﹤0.01% | 3376 |
|
|
2018
Q2 | $5.52M | Buy |
2,412,348
+444,844
| +23% | +$859K | ﹤0.01% | 3180 |
|
|
2018
Q1 | $2.97M | Buy |
1,967,504
+362,246
| +23% | +$424K | ﹤0.01% | 3330 |
|
|
2017
Q4 | $1.23M | Buy |
1,605,258
+638,932
| +66% | +$571K | ﹤0.01% | 3562 |
|
|
2017
Q3 | $1.12M | Buy |
966,326
+360,635
| +60% | +$454K | ﹤0.01% | 3561 |
|
|
2017
Q2 | $1.05M | Sell |
605,691
-294,876
| -33% | -$627K | ﹤0.01% | 3555 |
|
|
2017
Q1 | $2.38M | Buy |
900,567
+2,874
| +0.3% | +$10.3K | ﹤0.01% | 3329 |
|
|
2016
Q4 | $3.81M | Buy |
897,693
+22,844
| +3% | +$75.3K | ﹤0.01% | 3154 |
|
|
2016
Q3 | $2.33M | Buy |
874,849
+10,043
| +1% | +$23.1K | ﹤0.01% | 3327 |
|
|
2016
Q2 | $1.53M | Buy |
864,806
+7,773
| +0.9% | +$15.9K | ﹤0.01% | 3470 |
|
|
2016
Q1 | $1.99M | Buy |
857,033
+89,592
| +12% | +$203K | ﹤0.01% | 3383 |
|
|
2015
Q4 | $2.66M | Buy |
767,441
+48,088
| +7% | +$230K | ﹤0.01% | 3280 |
|
|
2015
Q3 | $4.41M | Buy |
719,353
+25,404
| +4% | +$172K | ﹤0.01% | 3023 |
|
|
2015
Q2 | $4.58M | Buy |
693,949
+41,161
| +6% | +$278K | ﹤0.01% | 3057 |
|
|
2015
Q1 | $4.65M | Buy |
+652,788
| New | +$4.92M | ﹤0.01% | 3033 |
|
Other funds holding GEN
IC
TRCT
Vanguard Group's GEN Position: Q1 2021 in Review
Vanguard Group sold out of Genesis Healthcare, Inc. (GEN) in Q1 2021, closing a stake of 1,735,802 shares — an estimated $841K sold.
Vanguard Group first reported a position in GEN in Q1 2015 and held it in 24 quarters. The position peaked at $5.52M in Q2 2018. 8 funds tracked by Wall St. Rank hold GEN as of Q1 2021.
- Vanguard Group reported no remaining Genesis Healthcare, Inc. position as of Q1 2021 after selling out during the quarter.
- Vanguard Group sold 1,735,802 Genesis Healthcare, Inc. shares in Q1 2021, an estimated $841K.
- Vanguard Group first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 24 quarters.
- Vanguard Group's Genesis Healthcare, Inc. position peaked at $5.52M in Q2 2018.
- 8 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2021.
Based on Vanguard Group's 13F filing for Q1 2021, filed 14 May 2021.